Relative Bioavailability

Relative Bioavailability is a pharmacokinetic measure of comparative bioavailability that quantifies the rate and extent of absorption of a drug from a test formulation relative to a reference non-intravenous formulation of the same drug under equivalent dosing conditions, typically expressed as the ratio of their systemic exposure (e.g., AUC and, where relevant, Cmax).

195

Publications

8.5K

Citations

782

Authors

276

Institutions

Publications per year

2017–2026

3

Authors

782

  1. RL
    Robert L. Kriel

    University of Minnesota, United States

    5 publications · 166 citations

    5

    h-index

  2. KS
    Kenneth S. Albert

    W.E. Upjohn Institute for Employment Research, United States

    4 publications · 107 citations

    4

    h-index

  3. JC
    James C. Cloyd

    University of Minnesota, United States

    4 publications · 144 citations

    4

    h-index

  4. SC
    Shein‐Chung Chow

    Duke University, United States

    4 publications · 128 citations

    4

    h-index

  5. IW
    I. Walter‐Sack

    Heidelberg University, Germany

    3 publications · 143 citations

    3

    h-index

1–5 of 782

Venues

  1. PubMed

    Repository · 28 publications · 963 citations

    16

    h-index

  2. European Journal of Clinical Pharmacology

    12 publications · 593 citations

    12

    h-index

  3. British Journal of Clinical Pharmacology

    BJCP · 10 publications · 619 citations

    10

    h-index

  4. The Journal of Clinical Pharmacology

    10 publications · 621 citations

    10

    h-index

  5. Journal of Pharmaceutical Sciences

    11 publications · 383 citations

    10

    h-index

1–5